Teladoc Health (TDOC) Projected to Post Quarterly Earnings on Tuesday

Teladoc Health (NYSE:TDOC) will likely be issuing its quarterly earnings data before the market opens on Tuesday, February 18th. Analysts expect the company to announce earnings of ($0.21) per share and revenue of $639.44 million for the quarter. Parties interested in participating in the company’s conference call can do so using this link.

Teladoc Health Stock Up 6.3 %

NYSE TDOC opened at $14.36 on Friday. Teladoc Health has a 12 month low of $6.76 and a 12 month high of $21.74. The company’s 50 day simple moving average is $10.28 and its 200 day simple moving average is $9.28. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. The company has a market capitalization of $2.47 billion, a P/E ratio of -2.49 and a beta of 1.05.

Analyst Upgrades and Downgrades

TDOC has been the topic of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft boosted their price target on shares of Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a report on Friday, November 1st. The Goldman Sachs Group initiated coverage on shares of Teladoc Health in a report on Friday, November 15th. They set a “buy” rating and a $14.00 price target on the stock. TD Cowen cut their price target on shares of Teladoc Health from $9.00 to $8.00 and set a “hold” rating on the stock in a report on Thursday, October 31st. Oppenheimer cut their price target on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a report on Friday, January 24th. Finally, Royal Bank of Canada boosted their price target on shares of Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a report on Friday, January 24th. Fourteen investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $12.08.

Insiders Place Their Bets

In related news, insider Carlos Nueno sold 2,389 shares of the company’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $11.93, for a total transaction of $28,500.77. Following the completion of the sale, the insider now directly owns 2,890 shares of the company’s stock, valued at approximately $34,477.70. This represents a 45.25 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.95% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.